Qi Ling-yan, Jin Chun-lian, Lin Chang-kun, Ren Mei-hong, Dong Wen-han, Sun Kai-lai
Department of Medical Genetics, China Medical University, Shenyang, Liaoning, 110001 P. R. China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Aug;24(4):405-8.
To establish an effective method of genetic diagnosis on hemophilia A (HA) by detecting the inversion mutation in intron 22 of F8 gene.
Intron 22 inversion mutation in F8 gene was detected by using long distance-polymerase chain reaction (LD-PCR) and inversion-PCR (I-PCR) in 31 HA patients. The mothers of HA patients with intron 22 inversion mutation were selected to carrier diagnosis and amniotic fluid of the pregnant women with inversion mutation was collected at intermediate stage of gestation, and used to prenatal genetic diagnosis.
Seven patients showed F8 gene inversion mutation in thirty-one patients. Three in four mothers of HA patients with intron 22 inversion mutation were diagnosed as carriers. The prenatal diagnosis result indicated that the fetus conceived in the HA-carrier woman was normal individual.
The detection of intron 22 inversion mutation by LD-PCR and I-PCR is time-saving, and can be used in prenatal diagnosis on HA.
通过检测F8基因内含子22的倒位突变,建立一种有效的甲型血友病(HA)基因诊断方法。
采用长距离聚合酶链反应(LD-PCR)和倒位聚合酶链反应(I-PCR)检测31例HA患者F8基因内含子22倒位突变。选取F8基因内含子22倒位突变的HA患者母亲进行携带者诊断,并在妊娠中期采集倒位突变孕妇的羊水用于产前基因诊断。
31例患者中有7例显示F8基因倒位突变。F8基因内含子22倒位突变的HA患者母亲中,四分之三被诊断为携带者。产前诊断结果表明,HA携带者女性所怀胎儿为正常个体。
LD-PCR和I-PCR检测内含子22倒位突变省时,可用于HA的产前诊断。